1. De Backer, G., Ambrosioni, E., Borch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., et al. (2003a). European guidelines for CVD prevention in clinical practice. Third joint task force of European and other societies. European Journal of Cardiovascular Prevention and Rehabilitation, 1, S1–S78.
2. De Backer, G., Ambrosioni, E., Borch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., et al. (2003b). European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. European Heart Journal, 24, 1601–1610.
3. Fortman, S., & Marcovina, S. M. (1997). Lipoprotein(a), a clinically elusive lipoprotein particle. Circulation, 95(2), 295–296.
4. Leineweber, C., Kecklund, G., Janszky, I., Akerstedt, T., & Orth-Gomer, K. (2003). Poor sleep increases the prospective risk for recurrent events in middle aged women with coronary disease. The Stockholm Female Coronary Risk study. Journal of Psychosomatic Research, 54, 121–127.
5. Orth Gomer, K., Schnekiderman, N., Wang, H., Walldin, C., Blom, M., & Jernberg, T. (2009). Stress reduction prolongs life in women with coronary disease. The Stockholm Women’s intervention trial for coronary heart disease (SWITCHD). Circulation, 2, 25–32. Cardiovasc Qual Outcomes.